Floreo

Overview
Activities
News
Extended Reality?
Mental Health Tech?
Product stageSegments
Go-to-Market
?
AR/VR platforms
?

Floreo is a health tech company that creates VR-based behavioral therapy content aimed at children with neurodevelopmental disorders such as autism, accessible on Meta Quest 2 or an iPhone. The company claims to be the first behavioral therapy metaverse, and its clinical staff, which includes a licensed speech-language pathologist and neurodevelopmental pediatrician, develops lessons to teach social, behavioral, communication and life skills including basic eye contact or crossing the street. The platform also collects data from the users which can be used to develop customized treatment plans. Floreo offers its services to healthcare providers, individuals, and educators.

In 2023, the company received the Food and Drug Administration’s breakthrough device designation and has been accepted into the newer Total Product Life Cycle Advisory Program (TAP).

Revenue is generated via monthly subscriptions, priced at USD 69 for individuals, with custom pricing for healthcare providers and educators.

Key customers and partnerships

Floreo has been deployed by more than 100 providers in the US and has Medicaid approval in 5 states. The company also conducted over 17,000 therapy sessions (2022). Partnerships include that with Children’s Hospital of Philadelphia to research and trial the platform. It has also partnered with Arkansas Support Network (ASN) to provide their VR lessons to individuals with disabilities.

Funding and financials

The company’s most recent funding was in October 2022 when it raised USD 10 million in a Series A funding round led by Tenfore Holdings.

Competitors: None under coverage (Floreo creates VR-based behavioral therapy content aimed specifically at children with neurodevelopmental disorders).

HQ location:
1875 Connecticut Avenue Northwest 10th Floor Washington DC USA
Founded year:
2016
Employees:
11-50
IPO status:
Private
Total funding:
USD 12.1 mn
Last Funding:
USD 10.0 mn (Series A; Oct 2022)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.